Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Ring chromosome 16 is characterized bypostnatal growthdeficiency, intellectual disability, microcephaly, broad flat nasal bridge, down-turned mouth, low-set and dysmorphic (abnormally-shaped) ears and speech delay.To date, less than 10 cases have been reported in the medical literature.
Biomarker and diagnostic research for ring chromosome 16 has been reported in the published literature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for ring chromosome 16.
96 publications have been identified in PubMed for ring chromosome 16. Research spans Basic Science / Preclinical (66%), Epidemiology / Natural History (12%), and Review / Meta-Analysis (8%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 59 | 66% |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 2:52 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
11 |
12% |
Research summaries | 7 | 8% |
Clinical study results | 5 | 6% |
Patient case studies | 4 | 4% |
Testing and diagnosis research | 2 | 2% |
New treatment approaches | 2 | 2% |
Wang SX (2026). [PMID: 41765854](https://pubmed.ncbi.nlm.nih.gov/41765854/). *Physical review letters*. [Basic Science / Preclinical]
Ablikim M (2026). [PMID: 41723692](https://pubmed.ncbi.nlm.nih.gov/41723692/). *Physical review letters*. [Basic Science / Preclinical]
Glaser T (2026). [PMID: 41199695](https://pubmed.ncbi.nlm.nih.gov/41199695/). *Angewandte Chemie (International ed. in English)*. [Basic Science / Preclinical]
Schneider TP (2026). [PMID: 41614352](https://pubmed.ncbi.nlm.nih.gov/41614352/). *ACS applied materials & interfaces*. [Basic Science / Preclinical]
Wieliczka BM (2026). [PMID: 42136691](https://pubmed.ncbi.nlm.nih.gov/42136691/). *ACS Energy Lett*. [Review / Meta-Analysis]
Vettori K (2026). [PMID: 41725542](https://pubmed.ncbi.nlm.nih.gov/41725542/). *Chemical communications (Cambridge, England)*. [Case Report / Case Series]
Ablikim M (2026). [PMID: 41616357](https://pubmed.ncbi.nlm.nih.gov/41616357/). *Physical review letters*. [Basic Science / Preclinical]
Jamalinia M (2026). [PMID: 41236094](https://pubmed.ncbi.nlm.nih.gov/41236094/). *Aliment Pharmacol Ther*. [Review / Meta-Analysis]
Lipaev AM (2025). [PMID: 39972839](https://pubmed.ncbi.nlm.nih.gov/39972839/). *Physical review. E*. [Basic Science / Preclinical]
Wang X (2025). [PMID: 40183525](https://pubmed.ncbi.nlm.nih.gov/40183525/). *The journal of physical chemistry letters*. [Basic Science / Preclinical]